RIPK3-IN-1 (Cat No.:I015153) is a small molecule inhibitor of receptor-interacting protein kinase 3 (RIPK3), which is involved in cell death signaling pathways. By inhibiting RIPK3, RIPK3-IN-1 may prevent excessive cell death and inflammation associated with certain diseases, such as autoimmune disorders. It has shown promise in preclinical studies for the treatment of inflammatory diseases, including necroptosis-mediated tissue damage.
| Catalog Number | I015153 |
| CAS Number | 2361139-70-8 |
| Molecular Formula | C₂₉H₂₅FN₄O₄ |
| Purity | 95% |
| Storage | Store at -20°C |
| IUPAC Name | N-[4-[2-(cyclopropanecarbonylamino)pyridin-4-yl]oxy-2,3-dimethylphenyl]-1-(4-fluorophenyl)-2-oxopyridine-3-carboxamide |
| InChI | InChI=1S/C29H25FN4O4/c1-17-18(2)25(38-22-13-14-31-26(16-22)33-27(35)19-5-6-19)12-11-24(17)32-28(36)23-4-3-15-34(29(23)37)21-9-7-20(30)8-10-21/h3-4,7-16,19H,5-6H2,1-2H3,(H,32,36)(H,31,33,35) |
| InChIKey | PETCZXAONWLUFT-UHFFFAOYSA-N |
| SMILES | CC1=C(C=CC(=C1C)OC2=CC(=NC=C2)NC(=O)C3CC3)NC(=O)C4=CC=CN(C4=O)C5=CC=C(C=C5)F |
| Reference | [1]. Amy C Hart, et al. Identification of RIPK3 Type II Inhibitors Using High-Throughput Mechanistic Studies in Hit Triage. ACS Med Chem Lett. 2019 May 6;11(3):266-271. |
